India's Glenmark to conduct COVID-19 cure trial

Indian pharmaceutical company Glenmark got an approval from the Drug Controller General of India to conduct tests on COVID-19 patients with its anti-viral drug 'favipiravir', seen as a potential cure to the disease. The drug is a generic version of Avigan, a drug of Japanese company Fujifilm Chemicals. Shares of the company were up 9% on Wednesday.